Bristol-Myers Squibb and Pharmasset to evaluate combination treatment for chronic hepatitis C Jan. 12, 2011
Mercator Therapeutics and Pepscan Therapeutics join to optimize anticancer homing peptides Jan. 7, 2011
RSS